|
Apellis Pharmaceuticals Common
(APLS)
|
12.8 |
$692M |
|
10M |
68.30 |
|
United Therapeutics Corp Common
(UTHR)
|
11.3 |
$613M |
|
2.9M |
209.38 |
|
Argenx Se Sponsored ADR
(ARGX)
|
8.3 |
$447M |
|
1.3M |
353.05 |
|
Mirati Therapeutics Common
|
7.2 |
$388M |
|
5.6M |
69.84 |
|
Sarepta Therapeutics Common
(SRPT)
|
6.5 |
$351M |
|
3.2M |
110.54 |
|
Horizon Therapeutics Common
|
5.9 |
$317M |
|
5.1M |
61.89 |
|
Biomarin Pharmaceutical Common
(BMRN)
|
5.6 |
$301M |
|
3.6M |
84.77 |
|
Ascendis Pharma Sponsored ADR
(ASND)
|
5.4 |
$294M |
|
2.9M |
103.26 |
|
Amicus Therapeutics Common
(FOLD)
|
5.2 |
$280M |
|
27M |
10.44 |
|
Seagen Common
|
4.7 |
$255M |
|
1.9M |
136.83 |
|
Alnylam Pharmaceuticals Common
(ALNY)
|
4.1 |
$221M |
|
1.1M |
200.16 |
|
Xenon Pharmaceuticals Common
(XENE)
|
3.3 |
$177M |
|
4.9M |
36.10 |
|
Biocryst Pharmaceuticals Common
(BCRX)
|
2.1 |
$114M |
|
9.1M |
12.60 |
|
Iveric Bio Common
|
2.0 |
$106M |
|
5.9M |
17.94 |
|
Madrigal Pharmaceuticals Common
(MDGL)
|
1.8 |
$100M |
|
1.5M |
64.99 |
|
Krystal Biotech Common
(KRYS)
|
1.6 |
$89M |
|
1.3M |
69.70 |
|
Iovance Biotherapeutics Common
(IOVA)
|
1.6 |
$86M |
|
9.0M |
9.58 |
|
Syndax Pharmaceuticals Common
(SNDX)
|
1.0 |
$53M |
|
2.2M |
24.03 |
|
Mersana Therapeutics Common
|
0.9 |
$51M |
|
7.6M |
6.76 |
|
Kura Oncology Common
(KURA)
|
0.9 |
$48M |
|
3.5M |
13.66 |
|
Kymera Therapeutics Common
(KYMR)
|
0.9 |
$47M |
|
2.2M |
21.77 |
|
Aadi Biosciences Common
(WHWK)
|
0.7 |
$40M |
|
2.8M |
14.13 |
|
Design Therapeutics Common
(DSGN)
|
0.7 |
$37M |
|
2.2M |
16.72 |
|
Pmv Pharmaceuticals Common
(PMVP)
|
0.7 |
$36M |
|
3.1M |
11.90 |
|
Cymabay Therapeutics Common
|
0.7 |
$36M |
|
10M |
3.50 |
|
Ultragenyx Pharmaceutical Common
(RARE)
|
0.6 |
$31M |
|
750k |
41.41 |
|
Mannkind Corp Common
(MNKD)
|
0.5 |
$28M |
|
9.1M |
3.09 |
|
Monte Rosa Therapeutics Common
(GLUE)
|
0.5 |
$28M |
|
3.4M |
8.17 |
|
Avidity Biosciences Common
(RNA)
|
0.4 |
$24M |
|
1.5M |
16.33 |
|
Dice Therapeutics Common
|
0.4 |
$22M |
|
1.1M |
20.28 |
|
Marinus Pharmaceuticals Common
|
0.4 |
$21M |
|
3.2M |
6.65 |
|
Nuvalent Common
(NUVL)
|
0.4 |
$20M |
|
1.0M |
19.44 |
|
Amylyx Pharmaceuticals Common
(AMLX)
|
0.3 |
$18M |
|
650k |
28.15 |
|
Fennec Pharmaceuticals Common
(FENC)
|
0.2 |
$9.7M |
|
1.2M |
8.10 |
|
Relay Therapeutics Common
(RLAY)
|
0.2 |
$8.9M |
|
400k |
22.37 |
|
Amarin Corp Sponsored ADR
|
0.1 |
$6.5M |
|
6.0M |
1.09 |
|
Tango Therapeutics Common
(TNGX)
|
0.1 |
$5.6M |
|
1.6M |
3.62 |
|
Io Biotech Common
(IOBT)
|
0.1 |
$5.6M |
|
2.1M |
2.71 |
|
Bioatla Common
(BCAB)
|
0.1 |
$4.4M |
|
575k |
7.70 |